Related Experiment Video
Updated: Jun 15, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Pregnancy-associated cardiomyopathy occurring in a young patient with nephropathic cystinosis
Arun J Ramappa1, Jason R Pyatt
1Department of Cardiology, Royal Liverpool and Broadgreen University Teaching Hospitals NHS Trust, Prescot Street, Liverpool, United Kingdom.
Insights
Cystinosis, a rare metabolic disorder, rarely causes cardiac issues. This case highlights pregnancy-associated cardiomyopathy in a patient with nephropathic cystinosis, emphasizing distinct cardiac risks during pregnancy.
Area of Science:
- Cardiology
- Genetics
- Metabolic Disorders
Background:
- Cystinosis is a rare autosomal recessive metabolic disorder causing intracellular cystine accumulation and organ dysfunction.
- Nephropathic cystinosis primarily affects renal function, with cardiac disease being an infrequent complication.
- Advances in renal transplantation and cysteamine therapy have improved outcomes for nephropathic cystinosis.
Observation:
- A young adult female with nephropathic cystinosis and on hemodialysis developed acute cardiac failure and dilated cardiomyopathy.
- Cardiac symptoms emerged early postpartum following a stillbirth, coinciding with temporary cessation of cysteamine treatment.
- Pre-pregnancy echocardiograms showed no cardiac abnormalities, suggesting a pregnancy-related etiology.
Findings:
- Transthoracic echocardiography confirmed dilated cardiomyopathy, absent in prior scans.
- Investigations ruled out other common causes for the cardiomyopathy.
- The patient demonstrated a positive response to conventional cardiac treatment, with full functional recovery observed on follow-up.
Implications:
- This case suggests pregnancy-associated cardiomyopathy rather than direct cystinosis involvement, despite the patient's underlying condition.
- The early onset of heart failure aligns with a subset of pregnancy-associated cardiomyopathies, distinct from typical peripartum cardiomyopathy timelines.
- Similarities in patient characteristics and outcomes suggest a shared pathological process between this case and other pregnancy-associated cardiomyopathies, with an increased risk of premature delivery.
Abstract:
Cystinosis is a rare autosomal recessive metabolic disorder characterised by an intracellular accumulation of cystine leading to severe organ dysfunction. It affects renal function, has extra-renal complications but has rarely been associated with cardiac disease. Renal transplantation and cysteamine have dramatically improved the prognosis in the nephropathic form. We present the case of a young adult Caucasian female diagnosed with nephropathic cystinosis and receiving haemodialysis who subsequently developed dilated cardiomyopathy. She presented with acute cardiac failure occurring early after stillbirth following an unplanned pregnancy when her cysteamine had been stopped. Transthoracic echocardiography showed typical features of dilated cardiomyopathy which was absent on pre-pregnancy scans. Investigations failed to identify an underlying cause for her cardiomyopathy. She responded to conventional treatment and currently has had full recovery of her cardiac function confirmed on follow-up echocardiography. As cardiomyopathy rarely co-exists with cystinosis, we believe that this case represents pregnancy-associated cardiomyopathy rather than direct involvement by her cystinosis, particularly as a minority of pregnant patients with associated cardiomyopathy develop heart failure early before the conventional period for peripartum cardiomyopathy. Patient characteristics and maternal outcomes are similar, albeit with higher risk of premature delivery suggesting the same underlying pathological process.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Diabetic Nephropathy
Nephrotic Syndrome I : Introduction

